Identification of causal mutation in the crystallin, connexin, and paired box gene 6 (
In this study, forty eight members from seventeen families and 148 sporadic cases of childhood cataract were evaluated. Clinical and ophthalmologic examinations were performed on available affected and unaffected family members. Samples of genomic DNA were PCR amplified to screen for mutations in the candidate genes viz., alpha-A crystallin (
DNA sequencing analysis of
We describe here a family having anterior polar coronary cataract that co-segregates with the novel allele R77S of
Childhood cataract is the most common form of treatable blindness in children [
Biochemically up to 90% of the water soluble proteins in the vertebrate lens belong to α-, β-, and γ-crystallins. Being a part of small heat shock protein the α-crystallins form high-molecular aggregates and function as molecular chaperones. The β/γ-crystallin superfamily exhibits a characteristic Greek key motif, in a quadruple organization showing two in the NH2- and two in the COOH-terminal domain. Evolutionary analysis has demonstrated the relationship of crystallins to other stress proteins and is expressed in other tissues of the body as well [
The human gamma-crystallins (
Cases of childhood cataract were registered through Kasturba Hospital (KH), Manipal, India. Clinical details of the proband were recorded in all the cases. Ophthalmic investigation included slit lamp examination with dilated pupils, visual acuity testing, intraocular pressure measurement, and fundus examination done by a senior ophthalmologist (V.P.). In familial cases, identification of cataract phenotype and detailed examination of the affected as well as available unaffected family members were performed. A detailed pedigree of the kindred was ascertained by interviewing the parents or any available family member. Clinical details of the patients who previously had cataract extraction were obtained through medical records. Cases presenting conditions such as unilateral, congenital rubella, systemic disorders, traumatic, syndromic, and other known causes were excluded for further study. Seeking of informed consent from all participants and parents of the probands was in accordance with the Declaration of Helsinki and Institutional Ethical Committee of Manipal University. Blood samples were collected from available affected/unaffected members of the family.
Genomic DNA was extracted from peripheral blood leukocytes using phenol chloroform method [
|
|
|
|
|
|---|---|---|---|
|
|
1 |
CTCCAGGTCCCCGTGGTACCA |
254 |
|
|
|
GCGAGGAGAGGCCAGCACCAC |
|
|
|
2 |
CTGTCTCTGCCAACCCCAGCAG |
223 |
|
|
|
CCCCTGTCCCACCTCTCAGTGCC |
|
|
|
3 |
GGCAGCTTCTCTGGCATGGGG |
312 |
|
|
|
GGGGAGCCAGCCGAGGCAATG |
|
|
|
1 |
TCTGTGGGCATTTGCTGACCC |
292 |
|
|
|
GCTAACAGCATTGAAGTCTCTGCCC |
|
|
|
2 |
GACCCCACAGCTCTGGGACAGTC |
393 |
|
|
|
GGAGGGACTTTCAGTATCAGCTCCAAC |
|
|
|
3 |
CACGGCTGCTTATAGCCAGAGCC |
449 |
|
|
|
TCTATCTGACTGCAAAGCATGAATTATCTCC |
|
|
|
4 |
GCTTTGGGCACAGCGATGTTCTG |
744 |
|
|
|
GGCCCCTTCCTGGTCCCCA |
|
|
|
5 |
AGTGGTCATAGACACGTAGTGGGTGCAC |
706 |
|
|
|
CTGTTCCCAAACTTAGGGACACACGC |
|
|
|
6 |
CCCCTCGTTCACCCTCCCATCA |
506 |
|
|
|
CACTGTGTCCAAGGTCACACAGCTAAGC |
|
|
|
1&2 |
AGGTCCCTTTTGTGTTGTTTTTGCC |
462 |
|
|
|
CATGAGGAATTATACGGCAGGATTGG |
|
|
|
3 |
CAGACCAGCTCGCACAAGTTAAGG |
353 |
|
|
|
AAGAGCCACTTAGTGCAGGGAACACAAC |
|
|
|
1&2 |
TGCAAATCCCCTACTCACCAAAATGG |
518 |
|
|
|
AAAAAGATGGAAGGCAAAGACAGAGCC |
|
|
|
3 |
TTTGTTTACTCTTGCGTTTTCTGTCTGCC |
410 |
|
|
|
GAAAGAAAGACAGGGCTCTACTAGTGCC |
|
|
|
1&2 |
TGCATAAAATCCCCTTACCGCTGAG |
522 |
|
|
|
ACTCTGGCGGCATGATGGAAATC |
|
|
|
3 |
AGACTCATTTGCTTTTTTCCATCCTTCTTTC |
407 |
|
|
|
GAAAGAATGACAGAAGTCAGCAATTGCC |
|
|
|
1&2 |
GCAGCCCCACCCGCTCA |
599 |
|
|
|
GGGTAATACTTTGCTTATGTGGGGAG |
|
|
|
3 |
TGCTTTTCTTCTCTTTTTATTTCTGGGTCC |
400 |
|
|
|
AGTAAAGAAAGACACAAGCAAATCAGTGCC |
|
|
|
1 |
CGGGGCCTTCTTTGTTCTCTAGTCC |
877 |
|
|
|
AGGCCCAGGTGGCTCAACTCC |
|
|
|
1 |
CAGCCGGTGGCCCTGCC |
907 |
|
|
|
GTTGCCTGGAGTGCACTGCCC |
|
|
|
1 |
CTGCGATGCCTGTCCTGTGG |
539 |
|
|
|
TTGTCCTGCGGTGGCTCCTT |
|
|
|
1 |
CGCCCACCCTCATCTACCT |
549 |
|
|
|
GTGGGAACCCGATGGCAAC |
|
|
|
1 |
AGCTCAAGCAGGGCGTGACC |
542 |
|
|
|
CAAGGGCGGCTGGTGCATCT |
|
|
|
1 |
CCCCGGCGCTCAAGGCTTAC |
545 |
|
|
|
AACCCTTGTCCCCGCCACCC |
|
|
|
1 |
CTCATTTCCCGCTCTGGTTC |
300 |
|
|
|
AAGAGTGTGGGTGAGGAAGT |
|
|
|
2 |
CACACTCTTTATCTCTCACTCTCCAGCC |
300 |
|
|
|
AATAAAGCGAGAAAGAAGCGGAC |
|
|
|
3 |
TCAGAGAGCCCATCGACGTAT |
300 |
|
|
|
CTGTTTGTGGGTTTTGAGCC |
|
|
|
4 |
TTGGGAGTTCAGGCCTACCT |
153 |
|
|
|
GAAGTCCCAGAAAGACCAGA |
|
|
|
5 |
CCTCTTCACTCTGCTCTCTT |
257 |
|
|
|
ATGAAGAGAGGGCGTTGAGA |
|
|
|
5a |
TGAAAGTATCATCATATTTGTAG |
237 |
|
|
|
GGGAAGTGGACAGAAAACCA |
|
|
|
6 |
GTGGTTTTCTGTCCACTTCC |
299 |
|
|
|
AGGAGAGAGCATTGGGCTTA |
|
|
|
7 |
CAGGAGACACTACCATTTGG |
252 |
|
|
|
ATGCACATATGGAGAGCTGC |
|
|
|
8 |
GGGAATGTTTTGGTGAGGCT |
371 |
|
|
|
CAAAGGGCCCTGGCTAAATT |
|
|
|
9 |
GTAGTTCTGGCACAATATGG |
206 |
|
|
|
GTACTCTGTACAAGCACCTC |
|
|
|
10 |
GTAGACACAGTGCTAACCTG |
243 |
|
|
|
CCCGGAGCAAACAGGTTTAA |
|
|
|
11 |
TTAAACCTGTTTGCTCCGGG |
208 |
|
|
|
TTATGCAGGCCACCACCAGC |
|
|
|
12 |
GCTGTGTGATGTGTTCCTCA |
300 |
|
|
|
TGCAGCCTGCAGAAACAGTG |
|
|
|
13 |
CATGTCTGTTTCTCAAAGGGA |
957 |
|
|
GAACAATTAACTTTTGCTGGCC |
One affected member per family was screened for mutations in
RFLP analysis was performed using AluI restriction enzyme (New England Biolabs Ltd., NEB, Hitchin, Herts, UK) as per the manufacturer’s instructions in 10 µl volumes. The products were resolved on 2% agarose gel. The presence or absence of the AluI restriction site was checked in other family members and in 100 unrelated controls.
Samples showing mobility shift were subjected to direct sequencing using Big Dye terminator chemistry on an ABI 3130 genetic analyzer (Applied Biosystems). Sequencing reaction was run through a program which included 25 cycles of denaturation (96 °C for 10 s), annealing (50 °C for 5 s), and extension (60 °C for 4 min). Sequence data were analyzed by standard software and alignments done by
The study was performed on patients with familial nonsyndromic bilateral childhood cataract. During the period (March 2004 to April 2009) forty eight subjects from 17 families and 148 isolated cases with childhood cataract were evaluated. Among these, zonular cataract was most frequent (46%), followed by total (13%) posterior sub capsular (10%), and nuclear cataracts (8%). Blue dot, sutural, and membranous cataracts were also recorded. In family C-35 (
Pedigree of the C-35 family.
All exons and intron/exon boundaries and flanking sequences of the candidate genes,
We have identified a sequence alteration in exon 2 of
PAGE showing differential migration of affected samples by the SSCP method. The affected individuals (III:1, III:2, and II:4) showed differential banding pattern with an extra band on 8% PAGE and unaffected (II:3, II:5, and III:3) showed normal banding pattern. Arrow indicated the extra band and asterisk indicate the lanes showing differential migration.
Genomic organization showing the region of R77S mutation. Electropherogram showing C>A heterozygous transversion in exon 2
This single-nucleotide change created an additional Alu1 restriction site in exon 2 of
Restriction fragment length analysis of
Multiple sequence alignment of γD-crystallin protein in different species. Sequence alignment showing the phylogenetic conservation of arginine at amino acid position 77. The mutant sequence indicates the sequence with the mutation detected in C-35 family. Only 60 to 83 amino acids are shown in the alignment.
Taken overall, the co-segregation of R77S was seen only in affected members of the pedigree (C-35) and its absence in 200 normal chromosomes strongly suggest that the non-conservative R77S substitution might be a causative mutation rather than a benign polymorphism to be associated with the disease.
Sequencing of
|
|
|
||||
|---|---|---|---|---|---|
|
|
|
|
|
|
|
| CT |
CC |
CT |
CT |
CC |
|
| GG |
GA |
GG |
GG |
GA |
|
| CA |
CC |
CA |
CA |
CC |
|
| GG |
GA |
GG |
GG |
GA |
|
| CC | CT | CC | CC | CT | |
Haplotypes involving the alleles at the SNP loci listed above, derived from pedigree of the family (
Both normal and mutant proteins were analyzed for their structure. The R77S (in the processed protein) is situated in second Greek key motif in the linker region as the last amino acid before start of the next beta sheet. The isoelectric point (pI) was found to be almost same for both wild type (7.0) and mutant (6.58) proteins. Molecular weight of the mutant (20,669 Da) protein was similar to that of wild-type protein (20,738 Da). There was an increase in hydrophobicity at the mutant site and its neighborhood (
Hydrophobicity profile of wild-type and R77S mutant γD-crystallin protein. Dotted circle represent the shift in the hydrophobicity around the mutant site. The prediction was done by ProtScale program at Expasy server.
The prediction of structural differences between wild-type and mutant proteins was performed using
Genes reported to cause cataract-specific mutations include those of the crystallins, cytoskeletal proteins, membrane proteins, transcription factors, glucosaminyl transferase 2 chromatin modifying protein-4B, and transmembrane protein 114 (TMEM114) [
Human γD-crystallin is a monomeric eye lens protein that must remain soluble throughout life for lens transparency. It is composed of two highly homologous beta-sheet domains which interact through interdomain side chain contacts forming two structurally distinct regions, a central hydrophobic cluster and peripheral residues. The specificity of domain interface interactions is likely important for preventing incorrect associations in the high protein concentrations of the lens nucleus [
Many of the identified mutations in
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Ex2 |
c.43C>T |
p.Arg15Cys (R15C) |
AD |
Punctate cataract, juvenile progressive |
Caucasian |
[ |
| Ex2 |
c.43C>T |
p.Arg15Cys (R15C) |
AD |
Coralliform/nuclear |
Chinese |
[ |
| Ex2 |
c.43C>A |
p.Arg15Ser (R15S) |
AD |
Coralliform |
Chinese |
[ |
| Ex2 |
c.70C>A |
p.Pro24Thr (P24T) |
AD |
Lamellar |
Indian |
[ |
| Ex2 |
c.70C>A |
p.Pro24Thr (P24T) |
AD |
Cerulean |
Moroccan |
[ |
| Ex2 |
c.70C>A |
p.Pro24Thr (P24T) |
AD |
Coral-shaped, coralliform |
Caucasian |
[ |
| Ex2 |
c.70C>A |
p.Pro24Thr (P24T) |
AD |
Flaky, silica-like nuclear cataract |
Australian pedigrees of European ancestry |
[ |
| Ex2 |
c.70C>A |
p.Pro24Thr (P24T) |
AD |
Fasciculiform |
Chinese |
[ |
| Ex2 |
c.70C>A |
p.Pro24Thr (P24T) |
AD |
Coralliform |
Chinese |
[ |
| Ex2 |
c.70C>A |
p.Pro24Thr (P24T) |
AD |
Cerulean and Coralliform |
Saudi Arabian |
[ |
| Ex2 |
c.109C>A |
p.Arg37Ser (R37S) |
AD |
with protein crystallization |
Czech boy |
[ |
| Ex2 |
c.109C>A |
p.Arg37Ser (R37S) |
AD |
Nuclear golden crystal |
Chinese |
[ |
| Ex2 |
c.168C>G |
p.Tyr56Stop (Y56X) |
AD |
Nuclear |
Brazilian |
[ |
| Ex2 |
c.176G>A |
p.Arg59His (R59H) |
AD |
Aculeiform |
Macedonian |
[ |
| Ex2 |
c.181G>T |
p.Gly61Cys (G61C) |
AD |
Coralliform |
Chinese |
[ |
| Ex2 |
c.229C>A |
p.Arg77Ser (R77S) |
AD |
Anterior polar, Coronary |
Indian |
This study |
| Ex3 |
c.320A>C |
p.Glu107Ala (E107A) |
AD |
Nuclear |
Hispanic |
[ |
| Ex3 |
c.403C>A |
p.Tyr134Stop (Y134X) |
AD |
No data |
Danish |
[ |
| Ex3 |
c.418C>T |
p.Arg140Stop (R140X) |
AD |
Nuclear |
Indian |
[ |
| Ex3 |
c.470G>A |
p.Trp157Stop (W157X) |
AD |
Nuclear |
Indian |
[ |
| Ex3 | c.494delG | p.Gly165fs | AD | Nuclear | Chinese | [ |
In the 16 other families studied no putative mutation could be observed in the candidate genes screened which therefore makes it rather unlikely that the selected genes are involved in the cataract-forming process in these families. It prompts screening of other known candidate genes. This demonstrates that cataract need not arise only through point mutations but might be influenced also by many other factors, which may include unidentified modifier genes and other sequence variations. Detailed information about such factors and their precise role should enable one to understand the pathophysiology of cataracts and the biology of the lens in general.
We are grateful to the family members for their participation in this study. This study was financially supported by Department of Biotechnology, Government of India under Indo-German Co-operation (BT/IN/FRG/JRS/2003-’04) and TIFAC-CORE in Pharmacogenomics, Department of Science and Technology, Government of India.